InvestorsHub Logo
Followers 10
Posts 1244
Boards Moderated 0
Alias Born 10/12/2012

Re: None

Wednesday, 06/18/2014 12:58:13 PM

Wednesday, June 18, 2014 12:58:13 PM

Post# of 30990
crooked_analyst on the clown board, From today's Article in Bradenton Herald, today

Quote:
"We've cleaned up our act," Jenkins said.

Anatabloc had been improperly marketed for Alzheimer's based on anecdotal testimonies, he said.

However, the compound within the nutritional supplement showed promise, so the company is seeking FDA permission to begin drug testing trials to develop a drug to battle osteoarthritis, Jenkins said.

"It was for the most part somewhat of a consumer nutritional supplements products company, and now we are pursuing an FDA regulatory drug pathway," Jenkins said of Rock Creek's shift as a company.

Mullan's work with Alzheimer's, multiple sclerosis and other inflammatory-based diseases complement the basis of Rock Creek's anti-inflammatory developments, Jenkins added. Less"

Article at:
http://www.bradenton.com/2014/06/18/5210514/drug-company-rock-creek-relocating.html?sp=/99/179/186/

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.